Journals / Türk Patoloji Dergisi / 2019 / Cilt: 35 - Sayı: 1

Clinical Significance of Granulation Pattern in Corticotroph Pituitary Adenomas

Pages
9–14
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Recurrences were slightly more common in SGCTs; however,further studies including larger series are needed to be able to obtain more significant results.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The granulation pattern of pituitary tumors may be important to predict tumor behavior, treatment outcomes, and recurrences.Therefore, we compared densely granulated corticotroph tumor (DGCT) and sparsely granulated corticotroph tumor (SGCT) in terms ofclinicopathologic findings.Material and Method: A total of 41 patients (31 females/10 males) were assessed in the study.
📊
Key Findings & Data:DGCTs and SGCTs were compared in terms of clinical findings and treatmentoutcomes.Results: The majority of the patients (71%) had DGCTs (n=29); whereas 24% of the patients had SGCTs (n=10) and 5% of the patients hadCrooke’s cell tumors (n=2).
💡
Conclusion & Impact:Recurrences were slightly more common in SGCTs; however,further studies including larger series are needed to be able to obtain more significant results.
🔬Design:Experimental Field Trial
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The granulation pattern of pituitary tumors may be important to predict tumor behavior, treatment outcomes, and recurrences.Therefore, we compared densely granulated corticotroph tumor (DGCT) and sparsely granulated corticotroph tumor (SGCT) in terms ofclinicopathologic findings.Material and Method: A total of 41 patients (31 females/10 males) were assessed in the study. The granulation patterns were detected by PeriodicAcid-Schiff (PAS) and adrenocorticotropic hormone (ACTH) immunoreactivity. Diffuse and strong staining by PAS and ACTH were identifiedas DGCT, whereas faint staining by PAS and focal, weak staining by ACTH were identified as SGCT. Perinuclear ring-like patterns with lowmolecular weight keratin were identified as Crooke’s cell tumors. DGCTs and SGCTs were compared in terms of clinical findings and treatmentoutcomes.Results: The majority of the patients (71%) had DGCTs (n=29); whereas 24% of the patients had SGCTs (n=10) and 5% of the patients hadCrooke’s cell tumors (n=2). DGCTs and SGCTs were similar in terms of age, sex, estimated duration of disease, baseline cortisol and ACTH levels.SGCTs were larger than DGCTs (p=0.034). The remissions with surgery rates were similar between the groups; however, hypothalamic-pituitary-adrenal axis recovery time was longer in SGCTs (p=0.033). Persistent disease after surgery was slightly higher in DGCTs and recurrences werefrequent in SGCTs; however, the differences were not statistically significant.Conclusion: DGCTs are often small microadenomas, while SGCTs are larger. Recurrences were slightly more common in SGCTs; however,further studies including larger series are needed to be able to obtain more significant results.

🔖

Cite This Article

BİLGİÇ, B., DOĞANŞEN, S. Ç., YARMAN, S., TANRIKULU, S., YALIN, G. Y. (2022). Clinical Significance of Granulation Pattern in Corticotroph Pituitary Adenomas. Türk Patoloji Dergisi, Cilt: 35 - Sayı: 1, 9–14. https://ajindex.com/articles/640455

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. The diagnosis of Cushing’s syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab.2008;93:1526-40.
  2. Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A; Endocrine Society. Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline.JClinEndocrinolMetab.2015;100:2807-31.
  3. Syro LV, Rotondo F, Cusimano MD, Di Ieva A, Horvath E, Restrepo LM, Wong M, Killinger DW, Smyth H, Kovacs K. Current status on histological classification in Cushing’sdisease. Pituitary.2015;18:217-24. WorldHealthOrganizationClassificationofTumours.Pathology and Genetics of Tumours of Endocrine Organs. DeLellis RA, LloydRV,HeitzPU,EngC(eds).Lyon:IARCPress,2004. World Health Organization Classification of Tumours of Endocrine Organs. Lloyd RV, Osamura RY, Klöppel G, Rosai J (eds). 4thed. Lyon: IARC Press,2017. AsaSL,EzzatS.Thepathogenesisofpituitarytumors.AnnuRev Pathol2009;4:97-126.
  4. Saeger W, Honegger J, Theodoropoulou M, Knappe UJ, Schöfl C, Petersenn S, Buslei R. Clinical Impact of the Current WHO Classification of Pituitary Adenomas. Endocr Pathol. 2016;27:104-14.
  5. Mete O, Asa SL. Clinicopathological correlations in pituitary adenomas. Brain Pathology.2012;22:443-53. Asa SL. Tumors of the Pituitary Gland. Fascicle 15, 4th Series. The Atlas of Tumor Pathology. Washington DC: Armed Forces Institute of Pathology,2011.
  6. Di Ieva A, Davidson JM, Syro LV, Rotondo F, Montoya JF, HorvathE,CusimanoMD,KovacsK.Crooke’scelltumorsofthe pituitary. Neurosurgery.2015;76:616-22.
  7. Lindsay JR, Oldfield EH, Stratakis CA, Nieman LK. The postoperativebasalcortisolandCRHtestsforpredictionoflong- term remission from Cushing’s disease after transsphenoidal surgery.JClinEndocrinolMetab.2011;96:2057-64. WitekP,ZielińskiG,SzamotulskaK,MaksymowiczM,Kamiński G. Clinicopathological predictive factors in the early remission of corticotroph pituitary macroadenomas in a tertiary referral centre. Eur J Endocrinol. 2016;174:539-49.
  8. Mete O, Cintosun A, Pressman I, Asa SL. Epidemiology and biomarker profile of pituitary adenohypophysial tumors. Mod Pathol.2018;31:900-9.
  9. Dekkers OM, Horváth-Puhó E, Jørgensen JO, Cannegieter SC, Ehrenstein V, Vandenbroucke JP, Pereira AM, Sørensen HT. Multisystem morbidity and mortality in Cushing’s syndrome: A cohortstudy.JClinEndocrinolMetab.2013;98:2277-84. ClaytonRN.MortalityinCushing’sdisease.Neuroendocrinology. 2010;92 Suppl1:71